Anaphylaxis
📧 Sign up to get email alerts when something new happens for Anaphylaxis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-03-03FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Epipen (epinephrine auto-injector) from Viatris Specialty LLC.
-
CLINICAL_TRIALS research · 2015-12-11Clinical Trial Update: Evaluation of the Sphingolipid Metabolite S1P as a Novel Biomarker in Food Allergy
This clinical trial update evaluates whether the sphingolipid metabolite S1P can serve as a biomarker for food allergy and related anaphylax…
-
FDA approval · 2015-12-03FDA Approved: EPINEPHRINE — Supplemental Application (BPI Labs, LLC)
FDA approved a supplemental application for EPINEPHRINE from BPI Labs, LLC (NDA 205029). This action finalizes an update to the product's la…
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: A Study to Evaluate the Incidence of Hypersensitivity After Administration of Sugammadex in Healthy Participants (MK-8616-101) [Phase 1]
Phase 1 trial assessing hypersensitivity incidence after sugammadex administration in healthy participants; results completed with posted re…
-
FDA approval · 2015-04-22FDA Approved: AUVI-Q — Supplemental Application (kaleo, Inc)
The FDA approved a supplemental application for AUVI-Q, the epinephrine auto-injector from Kaleo, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-10-23FDA Approved: EPINEPHRINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York LLC supplemental application for epinephrine.
-
FDA approval · 2014-10-13FDA Approved: EPINEPHRINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA granted a supplemental approval for epinephrine to Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2014-07-29FDA Approved: EPINEPHRINE — Original Application (BPI Labs, LLC)
The FDA approved an original NDA for a new Epinephrine product from BPI Labs, LLC, for emergency treatment of anaphylaxis.
-
FDA approval · 2014-07-17FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for EPIPEN (epinephrine) submitted by Viatris Specialty LLC.
-
FDA approval · 2014-04-30FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for EpiPen (epinephrine) from Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing Anaphylaxis
This completed clinical trial update describes mechanisms of desensitization of human mast cells and discusses how this approach may help pr…
-
FDA approval · 2014-03-22FDA Approved: AUVI-Q — Supplemental Application (kaleo, Inc)
The FDA approved a supplemental application for AUVI-Q (epinephrine auto-injector) from Kaleo, Inc., for the emergency treatment of anaphyla…
-
FDA approval · 2013-12-18FDA Approved: ADRENALIN — Original Application (Par Health USA, LLC)
FDA approves the Original Application for ADRENALIN (epinephrine) from Par Health USA, LLC, marking a new drug approval.
-
FDA approval · 2013-12-13FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Epipen (epinephrine) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: Potential Allergens in Wine: Double-blind Placebo-controlled Trial [NA]
A completed double-blind, placebo-controlled clinical trial investigating potential allergens in wine.
-
FDA approval · 2013-11-08FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for EPIPEN (epinephrine autoinjector) by Viatris Specialty LLC.
-
FDA approval · 2013-09-16FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for EPIPEN (epinephrine) submitted by Viatris Specialty LLC. The action relates to a supplemental fi…
-
FDA approval · 2013-09-06FDA Approved: EPINEPHRINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for epinephrine filed by Amneal Pharmaceuticals of New York LLC, resulting in changes to the existin…
-
FDA approval · 2013-07-23FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Epipen (epinephrine) submitted by Viatris Specialty LLC.
-
FDA approval · 2012-08-20FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Epipen (epinephrine) from Viatris Specialty LLC.
-
FDA approval · 2012-08-10FDA Approved: AUVI-Q — Original Application (kaleo, Inc)
The FDA approved AUVI-Q, an epinephrine autoinjector from Kaleo, under its Original Application for the treatment of anaphylaxis.
-
CLINICAL_TRIALS research · 2012-07-04Clinical Trial Update: Clinical Investigation on Allergic-like Reactions and Oculo-respiratory Syndrome After the H1N1 Pandemic Vaccine
This clinical trial update investigates allergic-like reactions and oculo-respiratory syndrome following the H1N1 pandemic influenza vaccine…
-
CLINICAL_TRIALS trial_result · 2012-06-15Clinical Trial Update: The Utility of Serum Tryptase in the Diagnosis of Shrimp- Induced Anaphylaxis [NA]
This completed clinical trial evaluated whether measuring serum tryptase can aid in diagnosing shrimp-induced anaphylaxis.
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine [NA]
Completed clinical trial comparing absorption of intranasal epinephrine with conventional intramuscular epinephrine for treating anaphylaxis…
-
CLINICAL_TRIALS research · 2011-03-31Clinical Trial Update: Clonal Mast Cell Disorders in Exercise-Induced Anaphylaxis
This clinical trial update describes research into clonal mast cell disorders associated with exercise-induced anaphylaxis.